Building on Chiba and Hokkaido university research, Think-Lands is aiming to commercialise microneedles manufactured with its optical vortex production system.
Think-Lands, a Japan-based microneedle manufacturer based on research from Chiba and Hokkaido universities, has obtained approximately ¥340m ($3m) in an equity and debt round featuring drug manufacturing contractor CMIC CMO, according to the Venture Times.
CMIC CMO took up equity alongside dental software developer Dof, seed-stage VC vehicle Real Tech Fund and investment firm AIS Capital, while Resona Bank agreed to supply Think Lands with a loan of undisclosed size.
Founded in 2014, Think-Lands is working on a…
